Eloxx Prescribed drugs Experiences Topline Outcomes from Part 2
Mixture of subcutaneous ELX-02 with ivacaftor didn’t obtain statistical significance for efficacy endpoints in Part 2 research in Class 1 CF ELX-02 was properly tolerated with no drug-related severe adversarial…